{"id":"https://openalex.org/W2944648227","doi":"https://doi.org/10.1210/js.2019-sat-091","title":"SAT-091 Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms","display_name":"SAT-091 Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms","publication_year":2019,"publication_date":"2019-04-01","ids":{"openalex":"https://openalex.org/W2944648227","doi":"https://doi.org/10.1210/js.2019-sat-091","mag":"2944648227"},"language":"en","primary_location":{"id":"doi:10.1210/js.2019-sat-091","doi":"https://doi.org/10.1210/js.2019-sat-091","is_oa":true,"landing_page_url":"https://doi.org/10.1210/js.2019-sat-091","pdf_url":null,"source":{"id":"https://openalex.org/S2735747656","display_name":"Journal of the Endocrine Society","issn_l":"2472-1972","issn":["2472-1972"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315851","host_organization_name":"Endocrine Society","host_organization_lineage":["https://openalex.org/P4310315851"],"host_organization_lineage_names":["Endocrine Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Endocrine Society","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1210/js.2019-sat-091","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082585914","display_name":"Manali Sapre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manali Sapre","raw_affiliation_strings":["Icahn School of Medicine at Mount Sinai, New York, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Icahn School of Medicine at Mount Sinai, New York, NY, United States","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085185312","display_name":"Douglas A. Tremblay","orcid":"https://orcid.org/0000-0002-4719-7192","observed_orcids":["https://orcid.org/0000-0002-4719-7192","https://orcid.org/0000-0003-2584-6953"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas Tremblay","raw_affiliation_strings":["Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, United States","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040375335","display_name":"Amanda Leiter","orcid":"https://orcid.org/0000-0001-9072-5512","observed_orcids":["https://orcid.org/0000-0001-9072-5512"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda Leiter","raw_affiliation_strings":["Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY, United States","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078020117","display_name":"Alexander R. Coltoff","orcid":"https://orcid.org/0000-0003-3563-5236","observed_orcids":["https://orcid.org/0000-0003-3563-5236"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander Coltoff","raw_affiliation_strings":["Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013936846","display_name":"Anita Geevarghese","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anita Geevarghese","raw_affiliation_strings":["Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014815821","display_name":"John Mascarhenas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Mascarhenas","raw_affiliation_strings":["Adult Leukemia Program, Myeloproliferative Disorders Clinical Research Program, Icahn School of Medicine at Mount Sinai, New York, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adult Leukemia Program, Myeloproliferative Disorders Clinical Research Program, Icahn School of Medicine at Mount Sinai, New York, NY, United States","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070276458","display_name":"Emily J. Gallagher","orcid":"https://orcid.org/0000-0002-7920-8474","observed_orcids":["https://orcid.org/0000-0002-7920-8474"]},"institutions":[{"id":"https://openalex.org/I4390039328","display_name":"Tisch Cancer Institute","ror":"https://ror.org/0317dzj93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1320796813","https://openalex.org/I4390039328","https://openalex.org/I98704320"]},{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily Gallagher","raw_affiliation_strings":["Dept of Endocrinology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Endocrinology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States","institution_ids":["https://openalex.org/I4390039328","https://openalex.org/I98704320"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3255,"currency":"USD","value_usd":3255},"apc_paid":{"value":3255,"currency":"USD","value_usd":3255},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.04697528,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"3","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":0.9900000095367432},{"id":"https://openalex.org/keywords/jak1-2-inhibition","display_name":"JAK1/2 inhibition","score":0.9800000190734863},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.9990000128746033},{"id":"https://openalex.org/keywords/myelofibrosis","display_name":"myelofibrosis","score":0.9710000157356262},{"id":"https://openalex.org/keywords/polycythemia-vera","display_name":"polycythemia vera","score":1.0},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.8700000047683716},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.9819999933242798},{"id":"https://openalex.org/keywords/metabolic-effects","display_name":"metabolic effects","score":0.609000027179718},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.6330000162124634},{"id":"https://openalex.org/keywords/serum-glucose","display_name":"serum glucose","score":0.6520000100135803},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.7630000114440918},{"id":"https://openalex.org/keywords/leptin-signaling","display_name":"leptin signaling","score":0.8230000138282776},{"id":"https://openalex.org/keywords/growth-hormone-signaling","display_name":"growth hormone signaling","score":0.8920000195503235},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.3919999897480011},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.5}],"concepts":[{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.9556126594543457},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8455561399459839},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.7329994440078735},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5457777380943298},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.43436500430107117},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3950842618942261},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.09177330136299133}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1210/js.2019-sat-091","doi":"https://doi.org/10.1210/js.2019-sat-091","is_oa":true,"landing_page_url":"https://doi.org/10.1210/js.2019-sat-091","pdf_url":null,"source":{"id":"https://openalex.org/S2735747656","display_name":"Journal of the Endocrine Society","issn_l":"2472-1972","issn":["2472-1972"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315851","host_organization_name":"Endocrine Society","host_organization_lineage":["https://openalex.org/P4310315851"],"host_organization_lineage_names":["Endocrine Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Endocrine Society","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6552330","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6552330","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Endocr Soc","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1210/js.2019-sat-091","doi":"https://doi.org/10.1210/js.2019-sat-091","is_oa":true,"landing_page_url":"https://doi.org/10.1210/js.2019-sat-091","pdf_url":null,"source":{"id":"https://openalex.org/S2735747656","display_name":"Journal of the Endocrine Society","issn_l":"2472-1972","issn":["2472-1972"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315851","host_organization_name":"Endocrine Society","host_organization_lineage":["https://openalex.org/P4310315851"],"host_organization_lineage_names":["Endocrine Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Endocrine Society","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2987221407","https://openalex.org/W2914339015","https://openalex.org/W3096087309","https://openalex.org/W4382725559","https://openalex.org/W7135549988","https://openalex.org/W3216402962","https://openalex.org/W4389343804","https://openalex.org/W4362540291","https://openalex.org/W7064399528","https://openalex.org/W2013377223"],"abstract_inverted_index":{"Background:":[0],"Ruxolitinib":[1],"is":[2,7,419],"a":[3,296,423],"JAK1/2":[4,80,387],"inhibitor":[5],"that":[6,57],"FDA":[8],"approved":[9],"to":[10,32,74,119,152,155,421],"treat":[11],"certain":[12],"myeloproliferative":[13],"neoplasms":[14],"(MPNs),":[15],"including":[16],"myelofibrosis":[17],"(MF)":[18],"and":[19,40,49,97,132,143,162,188,199,233,250,267,276,287,311,320,334,342,370,398,409,414],"polycythemia":[20],"vera":[21],"(PV).":[22],"The":[23],"JAK":[24],"family":[25],"kinases":[26],"are":[27,41,412],"targeted":[28],"in":[29,35,45,84,88,353,401],"cancers":[30],"due":[31],"their":[33,427],"role":[34],"cytokine":[36],"receptor":[37,51],"signal":[38],"transduction,":[39],"also":[42],"key":[43],"intermediates":[44],"growth":[46],"hormone,":[47],"leptin":[48],"prolactin":[50],"signaling.":[52],"Clinical":[53],"trials":[54],"have":[55],"reported":[56],"ruxolitinib":[58,83,113,307],"treatment":[59,111,214,220,308,364],"was":[60,95,215,231,234,248,283,315,329,340,350,389],"associated":[61,390],"with":[62,82,86,112,358,391],"weight":[63,230,392],"gain,":[64,393],"but":[65],"other":[66,192,225],"metabolic":[67,77,193,429],"consequences":[68,78],"remain":[69],"unknown.":[70],"Aim:":[71],"We":[72,146],"aimed":[73],"determine":[75],"the":[76,89,169,304,354,394],"of":[79,180,195,213,306,356,377,396,404,426],"inhibition":[81,388],"patients":[85,100,176,357,378],"MPN":[87,115],"clinical":[90],"setting.":[91],"Methods:":[92],"IRB":[93],"approval":[94],"obtained,":[96],"we":[98,302],"identified":[99],"from":[101,116,124,149,299],"an":[102],"electronic":[103],"medical":[104],"record":[105],"(EMR)":[106],"based":[107],"database":[108],"who":[109],"began":[110],"for":[114,186,219,260,365,383],"December":[117,120],"2011":[118],"2016.":[121],"Data":[122],"collected":[123],"EMRs":[125],"included":[126],"age,":[127],"gender,":[128],"weight,":[129,187],"height,":[130],"systolic":[131],"diastolic":[133],"blood":[134],"pressure":[135],"(SBP,":[136],"DBP),":[137],"medications,":[138],"co-morbidities,":[139],"random":[140],"serum":[141],"glucose,":[142],"lipid":[144,380],"profile.":[145],"compared":[147,167],"parameters":[148],"baseline":[150,198,229,247,271,319,333,339,368],"(prior":[151],"initiating":[153],"ruxolitinib)":[154],"72\u00b18":[156],"weeks":[157,238,254,281,346,372],"after":[158],"starting":[159],"treatment.":[160],"Baseline":[161],"72":[163,200,237,253,280,292,324,335,345,371],"week":[164],"data":[165,184,381],"were":[166,177,204,221],"using":[168],"Wilcoxon":[170],"signed":[171],"rank":[172],"test.":[173],"Results:":[174],"129":[175],"initially":[178],"identified,":[179],"which":[181],"71":[182],"had":[183,379],"available":[185,382],"at":[189,197,211,236,246,252,270,279,318,323,338,344,367],"least":[190],"one":[191],"parameter":[194],"interest":[196],"weeks.":[201,336],"Patient":[202],"characteristics":[203],"as":[205],"follows:":[206],"49.3%":[207],"male;":[208],"mean":[209],"age":[210],"initiation":[212],"64.6\u00b1SD11.1":[216],"years;":[217],"indications":[218],"MF":[222],"(77%),":[223],"PV(17%),":[224],"MPNs":[226],"(6%).":[227],"Mean":[228,241],"73.6\u00b116.9kg,":[232],"78.3\u00b18.9kg":[235],"(n=71,":[239],"p<0.001).":[240],"body":[242],"mass":[243],"index":[244],"(BMI)":[245],"25.6\u00b14.6kg/m2,":[249],"27.3\u00b15.4kg/m2":[251],"(n=68,":[255],"p<0.001).The":[256],"BMI":[257,297],"(kg/m2)":[258],"distribution":[259],"underweight":[261],"(<18.5),":[262],"normal":[263],"(18.5-24.9),":[264],"overweight":[265],"(25.0-29.9),":[266],"obese":[268],"(>30)":[269],"were:":[272],"3%,":[273],"43%,":[274],"41%,":[275],"13%,":[277],"respectively;":[278],"it":[282,418],"1%,":[284],"40%,":[285],"34%,":[286],"28%,":[288],"respectively":[289],"(p=0.002).":[290],"At":[291],"weeks,19%":[293],"moved":[294],"up":[295],"class":[298],"baseline.":[300],"Next,":[301],"investigated":[303],"effect":[305],"on":[309,363],"BP":[310],"glucose":[312],"concentrations.":[313],"SBP":[314,400],"124\u00b115":[316],"mmHg":[317,322],"129\u00b118":[321],"weeks,":[325],"(p=0.042,":[326],"n=71).":[327],"DBP":[328],"not":[330],"different":[331],"between":[332],"Glucose":[337],"99\u00b128mg/dL":[341],"101\u00b129mg/dL":[343],"(p=0.015,":[347],"n=59).":[348],"There":[349],"no":[351],"change":[352],"percent":[355],"hyperglycemia":[359],"(glucose":[360],"\u2265200mg/dL)":[361],"or":[362],"diabetes":[366],"(13.6%)":[369],"(13.6%).":[373],"An":[374],"insufficient":[375],"number":[376],"analysis.":[384],"Conclusions:":[385],"Systemic":[386],"development":[395],"obesity,":[397],"increased":[399],"this":[402],"cohort":[403],"patients.":[405],"As":[406],"pharmacological":[407],"JAK1":[408],"2":[410],"inhibitors":[411],"developed":[413],"more":[415],"widely":[416],"used,":[417],"important":[420],"gain":[422],"greater":[424],"understanding":[425],"long-term":[428],"consequences.":[430]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-05-16T00:00:00"}